• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Ascensia Diabetes Care

Senseonics expects to double global patient base in 2025, progresses with pump integration

March 3, 2025 By Sean Whooley

Senseonics logo

Senseonics (NYSE:SENS) shares ticked up after hours today on fourth-quarter results that came in ahead of the consensus forecast. Shares of SENS went up nearly 7% to 93¢ apiece in post-market trading today. The Germantown, Maryland-based long-term implantable continuous glucose monitor maker reported losses of $15.5 million for the quarter. That equals losses 2¢ per […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Implants, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Ascensia Diabetes Care, Senseonics

Ascensia Diabetes Care creates “wellness zone” for World Diabetes Day

November 14, 2024 By Sean Whooley

Ascensia Diabetes Care logo

Ascensia Diabetes Care today announced its plans to recognize World Diabetes Day 2024 with a virtual diabetes campaign. World Diabetes Day — Nov. 14 — recognizes the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. November is also the American Diabetes Association’s National Diabetes Awareness Month. […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Patient Monitoring, Technology Tagged With: Ascensia Diabetes Care, National Diabetes Awareness Month 2024, World Diabetes Day 2024

What diabetes tech companies are doing on World Diabetes Day 2024

November 14, 2024 By Sean Whooley

World Diabetes day

World Diabetes Day — today, Nov. 14 — brings out the best in the diabetes community that continues to innovate year after year. This date serves as a time to recognize these innovations as it marks the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. The […]

Filed Under: Diabetes, Drug-Device Combinations, Featured Tagged With: abbott, Ascensia Diabetes Care, Dexcom, embecta, Fresenius Medical Care, Insulet, Medtronic, National Diabetes Awareness Month 2024, World Diabetes Day 2024

Senseonics, Ascensia launch Eversense 365 year-long CGM in the U.S.

October 1, 2024 By Sean Whooley

Senseonics Ascensia Eversense 365 Product image

Ascensia Diabetes Care announced today that it launched the Eversense 365 CGM system from Senseonics (NYSE:SENS) in the U.S. Eversense 365, an implantable continuous glucose monitor (CGM), is indicated for people with type 1 and type 2 diabetes aged 18 years and older. Senseonics announced last month that it received FDA clearance for Eversense 365. With […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Ascensia Diabetes Care, Senseonics

Senseonics wins FDA nod for 365-day implantable CGM

September 17, 2024 By Sean Whooley

Senseonics Eversense 365 Product Image

Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system. Eversense 365, an implantable continuous glucose monitor (CGM), becomes the world’s first 365-day CGM system, according to the company. Its indications cover people with type 1 and type 2 diabetes aged 18 years and older. The system also received clearance […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Implants, Patient Monitoring, Regulatory/Compliance, Technology Tagged With: Ascensia Diabetes Care, FDA, Senseonics

The steps ahead for the Eversense implantable CGM platform

June 24, 2024 By Sean Whooley

Ascensia Senseonics Eversense E3 implantable long-term CGM

As Senseonics and Ascensia Diabetes Care looked for someone to help scale their CGM business, they turned to someone had only just retired. After close to eight years as Tandem Diabetes Care CCO, Brian Hansen notified the company of his decision to step down last August. His final day landed on Dec. 31, but he […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Implants, Patient Monitoring, Technology Tagged With: ADA 2024, Ascensia Diabetes Care, Senseonics

Senseonics wins integrated CGM designation from FDA, can work with insulin pumps

April 30, 2024 By Sean Whooley

Marketing image Senseonics Eversense E3 Ascensia Diabetes Care

The FDA today granted integrated CGM (iCGM) designation to the Eversense continuous glucose monitoring system from Senseonics (NYSE:SENS). With this designation, Eversense becomes the first fully implantable device in the category. Senseonics can now market the long-term CGM through the FDA’s de novo pathway. This establishes the special controls serving as a predicate device for […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Regulatory/Compliance, Technology Tagged With: Ascensia Diabetes Care, Senseonics

Ascensia, Senseonics announce new CGM cost savings

March 12, 2024 By Sean Whooley

Marketing image Senseonics Eversense E3 Ascensia Diabetes Care

Ascensia Diabetes Care and Senseonics today announced an extension to their Eversense Payment Assistance and Simple Savings (PASS) program. The program aims to help people in the U.S. access the Eversense E3 continuous glucose monitor (CGM) more affordably. It offers major savings for eligible individuals looking to experience the benefits of the long-term, implantable CGM. […]

Filed Under: Business/Financial News, Diabetes, Featured, Implants, Patient Monitoring, Technology Tagged With: Ascensia Diabetes Care, Senseonics

Senseonics earns expanded Medicare coverage for long-term implantable CGM

February 12, 2024 By Sean Whooley

Marketing image Senseonics Eversense E3 Ascensia Diabetes Care

Senseonics (NYSE:SENS) and Ascensia Diabetes Care today announced expanded Medicare coverage for the Eversense E3 CGM system. Medicare implemented Local Coverage Determinations (LCDs) providing access to implantable CGM for basal-only patients. It significantly expands access to Senseonics’ long-term (six months) implantable glucose monitor. The expansion for implantable CGMs includes all people with diabetes using insulin. […]

Filed Under: Business/Financial News, Diabetes, Featured, Implants, Patient Monitoring, Regulatory/Compliance, Technology Tagged With: Ascensia Diabetes Care, Senseonics

Former Tandem CCO joins Ascensia as president of CGM

February 6, 2024 By Sean Whooley

ascensia diabetes care senseonics

Ascensia Diabetes Care parent company PHC Holdings and Senseonics announced today that Ascensia named Brian Hansen its president of CGM. Hansen’s appointment to the newly created role at the global distributor of Senseonics’ Eversense CGM went into effect today, Feb. 6. Responsibilities for Hansen include the global commercialization and growth of the Eversense system. The fully […]

Filed Under: Diabetes, Featured, Implants, Patient Monitoring, Personnel, Technology Tagged With: Ascensia Diabetes Care, Personnel Moves, Senseonics

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS